|
|
| Research article summary (published 30 Jul 2006): |
Evaluating drug safety in children and adolescents with bipolar disorder.
Full Abstract
The safety of the use of medications in adolescents and children to treat bipolar disorder has not been extensively studied. The prevalence of bipolar disorder in children and adolescents is unknown due to the lack of completed large-scale epidemiological studies. In addition, the diagnosis of this disorder is still questionable in this age group because the same explicit diagnostic criteria used in adults potentially cannot be applied to children and adolescents since the early-onset symptoms often overlap with other disorders such as attention-deficit disorder. The safety of drugs used to treat bipolar disorder is of growing concern, particularly because this population usually requires more than one psychotropic medication to manage the disease. Common side effects seen with several agents, particularly antipsychotics, are somnolence, weight gain, extrapyramidal symptoms, dyslipidemia, type-2 diabetes, and hyperprolactinemia. This review will discuss the most advanced practice guidelines in assessing and treating bipolar disorder in children and adolescents, the safety and effectiveness of the drugs currently used based on clinical trials and post-marketing surveillance, and the risks versus benefits associated with their use.
Author information
Author/s: Heaton, Pamela C (PC); Garlick, Colleen M (CM); Tran, Doan (D);
Affiliation: Division of Pharmacy Practice, College of Pharmacy, University of Cincinnati, 3225 Eden Avenue, Cincinnati, OH 45267, USA. Pam.Heaton(-atsign-)uc.edu
Journal and publication information
Publication Type: Journal Article; Review
Journal: Current drug safety (Curr Drug Saf), published in Unknown. (Language: eng)
Reference: 2006-Aug; vol 1 (issue 3) : pp 307-18
Dates: Created 2008/08/11; Completed 2008/09/03;
PMID: 18690942, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
30 Dec 2005 - The efficacy of atypical antipsychotics in bipolar disorders.
30 Dec 2002 - Comparative efficacy and tolerability of drug treatments for bipolar disorder.
30 Dec 2000 - Update on the treatment and management of schizophrenia and bipolar disorder.
30 Jan 2008 - Recent advances in the treatment of bipolar mania, depression, mixed states, and rapid cycling.
29 Jun 2000 - Cognition in bipolar disorder.
30 May 2005 - The expanding pharmacopoeia for bipolar disorder.
30 Dec 2001 - Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy.
30 Dec 2006 - A successful effort to improve adherence to treatment guidelines for bipolar disorder.
30 Dec 2007 - Evolving trends in the long-term treatment of bipolar disorder.
30 Dec 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.